Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function

Experimental Hematology

Volumn 37, Issue 9, 2009, Pages 1030-1037

  Erhardt, Joseph A ^a   Erickson Miller, Connie L ^a   Aivado, Manuel ^a   Abboud, Melanie ^a   Pillarisetti, Kodandaram ^a   Toomey, John R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; ELTROMBOPAG; PADGEM PROTEIN; PROTEIN KINASE B; RECOMBINANT THROMBOPOIETIN; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; THROMBOPOIETIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

BENZOIC ACIDS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDRAZINES; MALE; P-SELECTIN; PLATELET AGGREGATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; RECEPTORS, THROMBOPOIETIN; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 68549092703     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.06.011     Document Type: Article

References (30)

1. Wendling F. Thrombopoietin: its role from early hematopoiesis to platelet production. Haematologica 84 (1999) 158-166
2. Geddis A.E., Linden H.M., and Kaushansky K. Thrombopoietin: a pan-hematopoietic cytokine. Cytokine Growth Factor Rev 13 (2002) 61-73
3. Kaushansky K., and Drachman J.G. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 21 (2002) 3359-3367
4. Italiano J.E., and Shivdasani R.A. Megakaryocytes and beyond: the birth of platelets. J Thromb Hameost 1 (2003) 1174-1182
5. Demetri G.D. Targeted approaches for the treatment of thrombocytopenia. Oncologist 6 Suppl 5 (2001) 15-23
6. Kuter D.J. New thrombopoietic growth factors. Blood 109 (2007) 4607-4616
7. Debili N., Wendling F., Cosman D., et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85 (1995) 391-401
8. Chen J., Herceg-Harjacek L., Groopman J.E., and Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 86 (1995) 4054-4062
9. Majka M., Ratajczak J., Villaire G., et al. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Exp Hematol 30 (2002) 751-760
10. Kojima H., Hamazaki Y., Nagata Y., Todokoro K., Nagasawa T., and Abe T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemostat 74 (1995) 1541-1545
11. Schulze H., Ballmaier M., Welte K., and Germeshausen M. Thrombopoietin induces the generation of distinct Stat1, Stat3, Stata5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets. Exp Hematol 28 (2000) 294-304
12. Rodríguez-Liñares B., and Watson S.P. Thrombopoietin potentiates activation of human platelets in association with Jak2 and Tyk2 phosphorylation. Biochem J 316 (1996) 93-98
13. Ezumi Y., Takayama H., and Okuma M. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonist-induced aggregation of platelets in vitro. FEBS Lett 374 (1995) 48-52
14. Oda A., Miyakawa Y., Druker B.J., et al. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood 87 (1996) 4664-4670
15. Wun T., Paglieroni T., Hammond W.P., Kaushansky K., and Foster D.C. Thrombopoietin is synergistic with other hematopoietic growth factors and physiologic platelet agonists for platelet activation in vitro. Am J Hematol 54 (1997) 225-232
16. Tibbles H.E., Navara C.S., Hupke M.A., Vassilev A.O., and Uckun F.M. Thrombopoietin induces P-selectin expression on platelets and subsequent platelet/leukocyte interactions. Biochem Biophys Res Commun 292 (2002) 987-991
17. van Os E., Wu Y., Pouwels J.G., et al. Thrombopoietin increases platelet adhesion under flow and decreases rolling. Br J Haematol 121 (2003) 482-490
18. Jenkins J.M., Williams D., Deng Y., et al. Phase I clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 109 (2007) 4739-4741
19. Bussel J., Cheng G., Saleh M.N., et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357 (2007) 2237-2247
20. Bussel J., Provan D., Shamsi T., et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial. Lancet 373 (2009) 641-648
21. McHutchison J.G., Dusheiko G., Shiffman M.L., et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 357 (2007) 2227-2236
22. Erickson-Miller C., Delorme E., Tian S.S., et al. Preclinical activity of eltrombopag (SB-497115), an oral, non-peptide thrombopoietic growth factor. Stem Cells 27 (2009) 424-430
23. Bell D.N., Spain S., and Goldsmith H.L. Extracellular-free Ca++ accounts for the sex difference in the aggregation of human platelets in citrated platelet-rich plasma. Thromb Res 58 (1990) 47-60
24. 2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate. Circulation 96 (1997) 1488-1494
25. Kim M.J., Park S.H., Opella S.J., et al. NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains. J Biol Chem 282 (2007) 14253-14261
26. Nakamura T., Miyakawa Y., Miyamura A., et al. A novel nonpetidyl human c-mpl activator stimulates human megakaryocytopoiesis and thrombosis. Blood 107 (2006) 4300-4307
27. st ed (2007), Academic Press, Burlington, MA 241-254
28. Chen J., De S., Damron D.S., Chen W.S., Hay N., and Byzova T.V. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104 (2004) 1703-1710
29. Woulfe D., Jiang H., Morgans A., Monks R., Birnbaum M., and Brass L.F. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 113 (2004) 441-450
30. Harker L.A., Roskos L.K., Marzec U.M., et al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood 95 (2000) 2514-2522